Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism.

Abstract

BACKGROUND:

Alzheimer's disease (AD) is a neuropathology strongly associated with the activation of inflammatory pathways. Accordingly, inflammation resulting from obesity exacerbates learning and memory deficits in humans and in animal models of AD. Consequently, the long-term use of non-steroidal anti-inflammatory agents diminishes the risk for developing AD, but the side effects produced by these drugs limit their prophylactic use. Thus, plants natural products have become an excellent option for modern therapeutics. Malva parviflora is a plant well known for its anti-inflammatory properties.

METHODS:

The present study was aimed to determine the anti-inflammatory potential of M. parviflora leaf hydroalcoholic extract (MpHE) on AD pathology in lean and obese transgenic 5XFAD mice, a model of familial AD. The inflammatory response and Amyloid β (Aβ) plaque load in lean and obese 5XFAD mice untreated or treated with MpHE was evaluated by immunolocalization (Iba-1 and GFAP) and RT-qPCR (TNF) assays and thioflavin-S staining, respectively. Spatial learning memory was assessed by the Morris Water Maze behavioral test. Microglia phagocytosis capacity was analyzed in vivo and by ex vivo and in vitro assays, and its activation by morphological changes (phalloidin staining) and expression of CD86, Mgl1, and TREM-2 by RT-qPCR. The mechanism triggered by the MpHE was characterized in microglia primary cultures and ex vivo assays by immunoblot (PPAR-γ) and RT-qPCR (CD36) and in vivo by flow cytometry, using GW9662 (PPAR-γ inhibitor) and pioglitazone (PPAR-γ agonist). The presence of bioactive compounds in the MpHE was determined by HPLC.

RESULTS:

MpHE efficiently reduced astrogliosis, the presence of insoluble Aβ peptides in the hippocampus and spatial learning impairments, of both, lean, and obese 5XFAD mice. This was accompanied by microglial cells accumulation around Aβ plaques in the cortex and the hippocampus and decreased expression of M1 inflammatory markers. Consistent with the fact that the MpHE rescued microglia phagocytic capacity via a PPAR-γ/CD36-dependent mechanism, the MpHE possess oleanolic acid and scopoletin as active phytochemicals.

CONCLUSIONS:

M. parviflora suppresses neuroinflammation by inhibiting microglia pro-inflammatory M1 phenotype and promoting microglia phagocytosis. Therefore, M. parviflora phytochemicals represent an alternative to prevent cognitive impairment associated with a metabolic disorder as well as an effective prophylactic candidate for AD progression.

• Authors: Elisa Medrano-Jiménez, Itzia Jiménez-Ferrer Carrillo, Martha Pedraza-Escalona, Cristina E Ramírez-Serrano, Lourdes Álvarez-Arellano, Javier Cortés-Mendoza, Maribel Herrera-Ruiz, Enrique Jiménez-Ferrer, Alejandro Zamilpa, Jaime Tortoriello, Gustavo Pedraza-Alva, Leonor Pérez-Martínez
• Journal: Journal of neuroinflammation (J Neuroinflammation) Vol. 16 Issue 1 Pg. 143 (Jul 10 2019) ISSN: 1742-2094 [Electronic] England
• PMID: 31291963 (Publication Type: Journal Article)

Chemical References

• Anti-Inflammatory Agents
• PPAR gamma
• Plant Extracts

Topics

• Alzheimer Disease
• Animals
• Anti-Inflammatory Agents (pharmacology)
• Brain (drug effects, pathology)
• Cognitive Dysfunction (etiology, pathology)
• Diet, High-Fat (adverse effects)
• Disease Models, Animal
• Malva
• Maze Learning (drug effects)
• Mice
• Mice, Transgenic
• Microglia (drug effects, metabolism)
• PPAR gamma (metabolism)
• Phagocytosis (drug effects)
• Plant Extracts (pharmacology)
• Plant Leaves